» Articles » PMID: 22238841

Anxiety Disorders, Hypertension, and Cardiovascular Risk: a Review

Overview
Publisher Sage Publications
Specialty Psychiatry
Date 2012 Jan 14
PMID 22238841
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension, coronary heart disease (CHD), and anxiety disorders all cause substantial morbidity to patients and costs to the healthcare system. Associations between these diseases have been hypothesized and studied for decades. In particular, psychosocial stressors associated with anxiety disorders raise autonomic arousal via the hypothalamic-pituitary axis which increases circulating catecholamines. This heightened arousal is associated with an increased risk of hypertension and a pro-inflammatory state and, consequently, development of coronary heart disease. This association holds across the spectrum of anxiety disorders (generalized anxiety, posttraumatic stress disorder, panic disorder, and obsessive compulsive disorder) and also when controlling for comorbid conditions such as depression and physical ailments. Multiple cross sectional studies reveal a positive association between anxiety and hypertension. These associations are bidirectional, with those with hypertension being more likely to have anxiety and those with anxiety being more likely to have hypertension. However, a few studies have shown no association. Longitudinal studies point to an increased risk of development of hypertension in patients who suffer from anxiety. More convincing studies show links between anxiety symptoms and disorders, including panic disorder and PTSD, and cardiovascular outcomes. Drawing broad conclusions from these studies is challenging, however, given the multiplicity of scales used to measure anxiety disorders. Anxiety, hypertension, and CHD are common conditions seen in primary care, and anxiety may be an important predictor of future CHD outcomes. Better recognition of the association of these conditions and the possible roles of each in development of the other should alert primary care providers to be vigilant in monitoring and treating anxiety, hypertension, and CHD.

Citing Articles

Global Prevalence of Anxiety in Gastroenterology and Hepatology Outpatients: A Systematic Review and Meta-Analysis.

Storer B, Holden M, Kershaw K, Braund T, Chakouch C, Coleshill M Curr Gastroenterol Rep. 2025; 27(1):17.

PMID: 40014212 PMC: 11868238. DOI: 10.1007/s11894-025-00963-x.


Machine learning analysis of emerging risk factors for early-onset hypertension in the Tlalpan 2020 cohort.

Martinez-Garcia M, Gutierrez-Esparza G, Marquez M, Amezcua-Guerra L, Hernandez-Lemus E Front Cardiovasc Med. 2025; 11:1434418.

PMID: 39896047 PMC: 11782138. DOI: 10.3389/fcvm.2024.1434418.


Socioeconomic Gender Variables Impact the Association between Hypertension and Chronic Health Issues: Cross-Sectional Study.

Lindner S, Gisinger T, Klimek P, Kautzky-Willer A J Pers Med. 2024; 14(8).

PMID: 39202081 PMC: 11355497. DOI: 10.3390/jpm14080890.


Major depression is not associated with higher myocardial infarction rates: insights from a large database.

Meskal S, Gill M, Movahed M, Hashemzadeh M, Hashemzadeh M Future Cardiol. 2024; 20(11-12):619-625.

PMID: 39136382 PMC: 11520533. DOI: 10.1080/14796678.2024.2387939.


Associations of Anxiety Symptoms With 6-Year Blood Pressure Changes and Incident Hypertension: Results From the Hispanic Community Health Study/Study of Latinos.

Rosas C, Pirzada A, Durazo-Arvizu R, Gallo L, Talavera G, Elfassy T Ann Behav Med. 2024; 58(7):488-497.

PMID: 38810223 PMC: 11185088. DOI: 10.1093/abm/kaae026.